In cytoskeletal researches concerning the LIMK pathway, I realized that people determines levels of total LIMK2 where as they do determine levels of both pLIMK1 and pLIMK2 with a polyclonal antibody recognizing both phosphorylated forms at the same time. I do not understand why don't they use a phospho specific antibody only against pLIMK2 it the case where they only determine total levels of LIMK2 but not LIMK1.

Any idea?

Similar questions and discussions